Citation

Holt RIG. Diabetes Obes. Metab. 2005; 7(2): 205-207.

Copyright

(Copyright © 2005, John Wiley and Sons)

DOI

10.1111/j.1463-1326.2005.00473.x

PMID

unavailable

Abstract

[Abstract unavailable]

Language: en

Keywords

human; suicide; injury; mortality; clinical trial; C reactive protein; inflammation; pathogenesis; obesity; article; patient care; atherosclerosis; age distribution; heart infarction; hydroxymethylglutaryl coenzyme A reductase inhibitor; cardiovascular disease; coronary artery disease; screening test; glucose blood level; lipid blood level; diabetes mellitus; atorvastatin; cerivastatin; liver toxicity; pravastatin; glucose; insulin; potassium; dipeptidyl carboxypeptidase inhibitor; hyperglycemia; metoprolol; metabolic syndrome X; heart protection; hyperkalemia; muscle disease; perindopril; phlebitis; preoperative treatment; retina disease; trandolapril